Ramsay Générale de Santé Full Year 2024 Earnings: €0.49 loss per share (vs €0.45 profit in FY 2023)

Ramsay Générale de Santé (EPA:GDS) Full Year 2024 Results

Key Financial Results

• Revenue: €5.01b (up 6.5% from FY 2023).
• Net loss: €53.9m (down by 209% from €49.4m profit in FY 2023).
• €0.49 loss per share (down from €0.45 profit in FY 2023).

All figures shown in the chart above are for the trailing 12 month (TTM) period

The primary driver behind last 12 months revenue was the France segment contributing a total revenue of €3.41b (68% of total revenue). Notably, cost of sales worth €3.63b amounted to 73% of total revenue thereby underscoring the impact on earnings.Explore how GDS's revenue and expenses shape its earnings.

Ramsay Générale de Santé shares are down 9.7% from a week ago.

Risk Analysis

You should learn about the 2 warning signs we've spotted with Ramsay Générale de Santé.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.